Andrew J. Last Oncocyte Corp (OCX) insider trading activity

Andrew J. Last is Director of Oncocyte Corp. Currently has a direct ownership of 39,509 shares of OCX, which is worth approximately $112,205. The most recent transaction as insider was on Jul 01, 2025, when has been sold 35,000 shares (Common Stock, No Par Value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.5K

56.18% 3M change

56.18% 12M change

Total Value Held $112,205

Andrew J. Last Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2025	BUY Grant, award, or other acquisition	-	35,000 Added 46.97%	39,509 Common Stock, No Par V...
Jun 23 2023	BUY Grant, award, or other acquisition	-	20,000 Added 18.15%	90,170 Common Stock, No Par V...
Aug 17 2022	BUY Open market or private purchase	$17,400 $0.87 p/Share	20,000 Added 22.18%	70,170 Common Stock, No Par V...
Aug 15 2022	BUY Grant, award, or other acquisition	-	10,000 Added 16.62%	50,170 Common Stock, No Par V...
Jun 24 2022	BUY Exercise of conversion of derivative security	-	10,000 Added 19.93%	40,170 Common Stock, No Par V...
Jun 11 2021	BUY Exercise of in-the-money or at-the-money derivatives securities	$20,979 $3.0 p/Share	6,993 Added 18.82%	30,170 Common Stock
Dec 11 2020	BUY Grant, award, or other acquisition	-	16,184 Added 41.12%	23,177 Common Stock

Also insider at

BIO

BIO-RAD LABORATORIES, INC. Healthcare

EVP, Chief Operating Officer

AJL

Andrew J. Last

Director

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCX shares.

Notify only if

Value

Insider Trading

Get notified when an Oncocyte Corp insider buys or sells OCX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oncocyte Corp

Track Activities on OCX

Account